-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$43.3364.07% Upside
Royalty Pharma plc Frequently Asked Questions
-
What analysts cover Royalty Pharma plc?
Royalty Pharma plc has been rated by research analysts at Goldman Sachs, Morgan Stanley, UBS in the past 90 days.